These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Estrogens and Alzheimer disease]. Stähelin HB Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084 [TBL] [Abstract][Full Text] [Related]
4. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
5. [Effect of hormone replacement therapy on the cardiovascular system]. Payer J Cas Lek Cesk; 2001 Feb; 140(3):67-9. PubMed ID: 11284420 [TBL] [Abstract][Full Text] [Related]
7. [What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)]. Martin-Du Pan RC; Luzuy F Rev Med Suisse Romande; 2000 Jun; 120(6):515-21. PubMed ID: 11014096 [TBL] [Abstract][Full Text] [Related]
8. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Henderson VW Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963 [TBL] [Abstract][Full Text] [Related]
9. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases]. Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970 [No Abstract] [Full Text] [Related]
10. Oestrogens and the heart. Rosano GM; Panina G Therapie; 1999; 54(3):381-5. PubMed ID: 10500455 [TBL] [Abstract][Full Text] [Related]
11. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of American Society for Reproductive Medicine Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655 [TBL] [Abstract][Full Text] [Related]
12. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
14. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens. Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C Menopause; 1999; 6(2):134-7. PubMed ID: 10374220 [TBL] [Abstract][Full Text] [Related]
15. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536 [TBL] [Abstract][Full Text] [Related]
16. Benefits of hormone replacement therapy--overview and update. Calaf i Alsina J Int J Fertil Womens Med; 1997; 42 Suppl 2():329-46. PubMed ID: 9397382 [TBL] [Abstract][Full Text] [Related]
17. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause]. Lippert TH; Seeger H; Mueck AO Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819 [TBL] [Abstract][Full Text] [Related]
18. Landmark hormone replacement therapy study stopped after finding more harms than benefits. Rollins G Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323 [No Abstract] [Full Text] [Related]
19. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]